logo-loader
RNS
MicroSalt PLC

MicroSalt PLC - Result of AGM

RNS Number : 4873K
MicroSalt PLC
01 July 2026
 

1 July 2026

MicroSalt Plc

("MicroSalt" or the "Company")

Result of AGM

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, is pleased to announce that all resolutions proposed to shareholders at its Annual General Meeting were duly passed.

The total number of votes received in respect of all resolutions were as follows:

 

For

Against

Votes Withheld

Total votes cast

Number of Votes

%

Number of Votes

%

Ordinary Resolutions

1. Approval of Annual Report and Accounts

34,766,508

99.90%

33,980

0.10%

54

34,800,488

2. To re-appointment Crowe U.K. LLP as Auditors

34,760,383

99.90%

35,073

0.10%

5,086

34,795,456

3. To authorise Directors to set Auditors remuneration

34,758,383

99.90%

35,073

0.10%

7,086

34,793,456

4. To re-elect Judith Batchelar as a Director

34,336,743

98.69%

456,713

1.31%

7,086

34,793,456

5. To re-elect Rick Guiney as a Director

34,336,143

99.90%

35,695

0.10%

428,704

34,371,838

6. To re-elect Gary Urmston as a Director

34,336,143

98.69%

457,313

1.31%

7,086

34,793,456

7. To re-elect Daniel Emery as a Director

34,334,744

98.68%

458,712

1.32%

7,086

34,793,456

8. Authority to Allot Shares

34,309,399

98.62%

480,268

1.38%

10,875

34,789,667

Special Resolution

9. Disapplication of pre-emption rights

33,972,529

97.66%

815,139

2.34%

12,874

34,787,668









 

Notes:

1.   Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

2.   Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.   The number of shares in issue on 30 June 2026 was 55,911,374.

5.   The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://www.microsaltinc.com/.

For more information, please visit https://microsaltinc.com, follow on X @MicroSaltPLC or contact:

 

MicroSalt plc

Via Gracechurch Group

Rick Guiney, CEO 

 




Zeus (Nominated adviser and broker)




David Foreman / James Edis (Investment Banking)

+44 (0)20 3829 5000

 


Gracechurch Group (Financial PR) 

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott


 

About MicroSalt

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70% of the typical person's sodium intake is hidden in processed foods.

Operational since 2018, MicroSalt uses a patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market.

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also scope to enter the larger salt market.

MicroSalt is ideally positioned for scale and market leadership, with clear pathways into food manufacturing, consumer channels, and ultimately the broader £10+ billion global salt market. MicroSalt is more than a healthier alternative-it is a disruptive, category-defining solution poised to deliver significant commercial and societal impact.

For more information, please visit www.microsaltinc.com or follow on X @microSaltPLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFZGFVZGGGVZZ
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read